HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Marc-Henri Stern Selected Research
Marc-Henri Stern Research Topics
Disease
50
Neoplasms (Cancer)
04/2024 - 09/2006
13
Uveal melanoma
12/2023 - 07/2012
13
Breast Neoplasms (Breast Cancer)
12/2022 - 06/2007
8
Neoplasm Metastasis (Metastasis)
10/2023 - 04/2015
7
Triple Negative Breast Neoplasms
01/2023 - 05/2015
5
Melanoma (Melanoma, Malignant)
01/2022 - 01/2019
4
Ovarian Neoplasms (Ovarian Cancer)
11/2023 - 12/2017
4
Circulating Neoplastic Cells
01/2019 - 03/2014
3
Microsatellite Instability
12/2022 - 10/2018
3
Carcinoma (Carcinomatosis)
01/2016 - 01/2008
2
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2024 - 10/2019
2
Carcinogenesis
01/2023 - 01/2021
2
Ataxia Telangiectasia (Louis Bar Syndrome)
01/2020 - 10/2019
2
Mesothelioma
09/2017 - 02/2011
2
Leukemia
05/2007 - 08/2004
1
Lung Neoplasms (Lung Cancer)
01/2023
1
Neurodevelopmental Disorders
01/2022
1
Retinoblastoma (Glioblastoma, Retinal)
01/2020
1
Endometrial Neoplasms (Endometrial Cancer)
01/2020
1
Telangiectasis (Telangiectasia)
10/2019
1
Iron Overload
10/2019
1
Sarcoma (Soft Tissue Sarcoma)
01/2019
1
Colorectal Neoplasms (Colorectal Cancer)
01/2019
1
Residual Neoplasm
01/2017
1
Pancreatic Neoplasms (Pancreatic Cancer)
03/2016
1
Adenocarcinoma
03/2016
1
Hypersensitivity (Allergy)
01/2016
1
Metaplasia
03/2015
Drug/Important Bio-Agent (IBA)
13
DNA (Deoxyribonucleic Acid)
IBA
09/2023 - 06/2007
11
Biomarkers (Surrogate Marker)
IBA
10/2023 - 05/2010
10
Proteins (Proteins, Gene)
FDA Link
01/2022 - 08/2004
9
Circulating Tumor DNA
IBA
10/2023 - 07/2012
4
RNA Splicing Factors
IBA
04/2024 - 10/2019
4
Phenobarbital (Luminal)
FDA Link
12/2022 - 01/2009
3
Neoplasm Antigens (Tumor Antigens)
IBA
01/2024 - 01/2023
3
Antigens
IBA
01/2023 - 04/2020
3
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2023 - 02/2016
3
Platinum
IBA
01/2023 - 02/2016
3
Messenger RNA (mRNA)
IBA
01/2023 - 06/2013
3
Immune Checkpoint Inhibitors
IBA
01/2022 - 01/2018
3
Tumor Biomarkers (Tumor Markers)
IBA
01/2020 - 05/2015
3
RNA (Ribonucleic Acid)
IBA
02/2016 - 06/2007
2
olaparib
IBA
11/2023 - 12/2022
2
DNA Transposable Elements (Element, IS)
IBA
01/2023 - 01/2023
2
TES
IBA
01/2023 - 01/2023
2
Histones (Histone)
IBA
01/2023 - 09/2017
2
Peptides (Polypeptides)
IBA
01/2023 - 01/2023
2
Salts
IBA
12/2022 - 02/2016
2
Hormones (Hormone)
IBA
11/2019 - 02/2016
2
Nucleotides
IBA
01/2019 - 10/2013
2
Chromatin
IBA
04/2015 - 09/2006
2
Oncogene Proteins (Oncogene Protein)
IBA
08/2009 - 02/2008
1
MART-1 Antigen
IBA
01/2024
1
Bevacizumab (Avastin)
FDA Link
11/2023
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
04/2023
1
Epitopes
IBA
01/2023
1
Macrophage Colony-Stimulating Factor
IBA
01/2023
1
Methyltransferases
IBA
01/2023
1
Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)
IBA
01/2023
1
Ribose (D-Ribose)
IBA
12/2022
1
Poly Adenosine Diphosphate Ribose
IBA
12/2022
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
12/2022
1
Cell-Free Nucleic Acids
IBA
12/2022
1
Gemcitabine
FDA Link
11/2022
1
Cytidine
IBA
11/2022
1
Trastuzumab (Herceptin)
FDA Link
04/2022
1
Etoposide (VP 16)
FDA Link
Generic
04/2022
1
Type II DNA Topoisomerases (Topoisomerase II)
IBA
04/2022
1
palbociclib
IBA
01/2022
1
Aromatase Inhibitors
IBA
01/2022
1
A-Form DNA (A-DNA)
IBA
06/2021
1
Codon (Codons)
IBA
01/2021
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2021
1
Vaccines
IBA
04/2020
1
Melphalan (Alkeran)
FDA Link
Generic
01/2020
1
indimitecan
IBA
01/2020
1
tebentafusp
IBA
01/2020
1
Topoisomerase I Inhibitors
IBA
01/2020
1
Camptothecin
IBA
01/2020
1
Co-Repressor Proteins
IBA
01/2020
1
berzosertib
IBA
01/2020
1
Irinotecan (Camptosar)
FDA Link
Generic
01/2020
1
NSC 724998
IBA
01/2020
1
Iron
IBA
10/2019
1
Paraffin
IBA
01/2018
1
Formaldehyde (Formol)
FDA Link
01/2018
1
Ubiquitin
IBA
09/2017
1
Deubiquitinating Enzymes
IBA
09/2017
1
1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)
IBA
01/2017
1
Heterochromatin
IBA
04/2015
Therapy/Procedure
13
Therapeutics
04/2020 - 01/2008
6
Immunotherapy
12/2023 - 10/2018
3
Drug Therapy (Chemotherapy)
01/2023 - 01/2020
2
Neoadjuvant Therapy
12/2022 - 01/2017
2
Radiotherapy
12/2022 - 10/2013
2
Precision Medicine
07/2021 - 04/2015
1
Radical Mastectomy
12/2022
1
Segmental Mastectomy (Lumpectomy)
12/2022
1
Mastectomy (Mammectomy)
12/2022
1
Hepatectomy
01/2020